In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.
about
Imaging of small animal peripheral artery disease models: recent advancements and translational potentialA MicroRNA93-Interferon Regulatory Factor-9-Immunoresponsive Gene-1-Itaconic Acid Pathway Modulates M2-Like Macrophage Polarization to Revascularize Ischemic Muscle.ADAM12: a genetic modifier of preclinical peripheral arterial disease.PADPIN: protein-protein interaction networks of angiogenesis, arteriogenesis, and inflammation in peripheral arterial disease.Glycaemic control improves perfusion recovery and VEGFR2 protein expression in diabetic mice following experimental PADMicroRNA-93 controls perfusion recovery after hindlimb ischemia by modulating expression of multiple genes in the cell cycle pathwayEndothelial cell-by-cell profiling reveals the temporal dynamics of VEGFR1 and VEGFR2 membrane localization after murine hindlimb ischemia.Adeno-associated virus serotype 9 efficiently targets ischemic skeletal muscle following systemic delivery.Systems biology of pro-angiogenic therapies targeting the VEGF systemMyocyte specific overexpression of myoglobin impairs angiogenesis after hind-limb ischemia.VEGF and soluble VEGF receptor-1 (sFlt-1) distributions in peripheral arterial disease: an in silico model.Endothelial progenitor cells (EPCs) mobilized and activated by neurotrophic factors may contribute to pathologic neovascularization in diabetic retinopathy.A compartment model of VEGF distribution in humans in the presence of soluble VEGF receptor-1 acting as a ligand trapDysregulated selectin expression and monocyte recruitment during ischemia-related vascular remodeling in diabetes mellitusCorrelative Imaging of the Murine Hind Limb Vasculature and Muscle Tissue by MicroCT and Light Microscopy.Exercise-induced expression of angiogenic growth factors in skeletal muscle and in capillaries of healthy and diabetic mice.Obesity induced-insulin resistance causes endothelial dysfunction without reducing the vascular response to hindlimb ischemia.High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism.A quantitative trait locus (LSq-1) on mouse chromosome 7 is linked to the absence of tissue loss after surgical hindlimb ischemiaNitrite anion therapy protects against chronic ischemic tissue injury in db/db diabetic mice in a NO/VEGF-dependent manner.Ceramide-activated phosphatase mediates fatty acid-induced endothelial VEGF resistance and impaired angiogenesisAAV-mediated, optogenetic ablation of Müller Glia leads to structural and functional changes in the mouse retinaChronic inhibition of epidermal growth factor receptor tyrosine kinase and extracellular signal-regulated kinases 1 and 2 (ERK1/2) augments vascular response to limb ischemia in type 2 diabetic mice.VEGF and LPS synergistically silence inflammatory response to Plasmodium berghei infection and protect against cerebral malariaAngiogenesis and diabetes: different responses to pro-angiogenic factors in the chorioallantoic membrane assay.Increased antiangiogenic protein expression in the skeletal muscle of diabetic swine and patients.Chitin from the Extract of Cuttlebone Induces Acute Inflammation and Enhances MMP1 Expression.Effects of diabetes on myocardial capillary density and serum angiogenesis biomarkers in male ratsDevelopmental conditioning of the vasculature.Exercise performance and peripheral vascular insufficiency improve with AMPK activation in high-fat diet-fed mice.Trimodal rescue of hind limb ischemia with growth factors, cells, and nanocarriers: fundamentals to clinical trials.The n-Hexane, ethylacetate, and butanol fractions from Hydnocarpi Semen enhanced wound healing in a mice ulcer model.Metabolic Regulation of Angiogenesis in Diabetes and Aging.Niacin promotes revascularization and recovery of limb function in diet-induced obese mice with peripheral ischemia.Neovascular potential of adipose-derived stromal cells (ASCs) from diabetic patients.Curcumin induces therapeutic angiogenesis in a diabetic mouse hindlimb ischemia model via modulating the function of endothelial progenitor cellsSubacute limb ischemia induces skeletal muscle injury in genetically susceptible mice independent of vascular densityEarly oxidative shifts in mouse skeletal muscle morphology with high-fat diet consumption do not lead to functional improvements.Modulation of miR29a improves impaired post-ischemic angiogenesis in hyperglycemia.The vascular endothelial growth factor (VEGF)-E encoded by orf virus regulates keratinocyte proliferation and migration and promotes epidermal regeneration.
P2860
Q27009178-93B8D7B1-9B8C-4AB5-9B33-5C930EE5E876Q30252768-1A865E55-6270-4F11-B214-6B33062D3C64Q30279037-A07215FE-2A64-47E7-99F3-F1058270038EQ30279209-AA80E138-1317-4D16-8DD7-1F393439132FQ30407641-410161F1-4BFF-496F-A9B1-B9E3DD18338CQ30413602-4783E49A-8B77-4EAE-94A2-68B56BD0FA04Q30413823-E5A8C1C5-512D-4A95-8EBF-0B6813B9F5C8Q30414524-BCF48E72-A91A-4C10-AC67-52B91BB81F09Q30430112-A8BCB0DA-8101-47CB-9652-A80F16B6B2C1Q30431139-0235B075-4EF4-4CF6-A1A7-51DA453A87F3Q30432040-D9571022-5E10-431A-8750-CAC4411C7608Q30433579-57D72623-2C66-412E-BAB7-E4E3672087CFQ30439884-BC1C0993-61FE-4B7F-8FD7-26E87E2CE9A7Q30461411-50AE5A08-C6F5-4A60-A795-74B9FEA89709Q30837730-FA63816E-01A0-4309-BDD8-8284EA8F5688Q33331474-6D7B8F7A-55B5-48EA-A5C2-C61793FCD783Q33472763-101C406E-8F58-43D5-B7DF-8B4A216C3577Q33869816-8FDC79D7-79A3-472D-9104-4D06DA293ABAQ33895724-B66172D9-93D9-4530-87EB-303CA82AF283Q34263955-5E2C7030-E44A-4769-95F9-E3B6952BD730Q34408930-10A13A07-99E3-4CC9-B2CB-2E801163F303Q35006176-5A2AEDEC-C17A-457F-B49F-51B53187C5D8Q35917666-45B5C2A7-9F45-46FA-BE8A-0AA39C4AEFF7Q36504376-0AD6E952-F1FA-452E-90F1-1B154601FFE3Q36800392-B6ABE19F-15AE-40F9-A659-616B017D8583Q37045424-167B9492-E40B-412E-87E1-ED9A2FC86D00Q37314139-99E72A2F-0608-4FDD-944F-47FFB9758A1CQ38258872-A2A876C3-F913-49C7-8DD5-3F7C859EE51FQ38318645-6278111C-20B3-4389-A76F-EF3C952C08F3Q38799483-CCD3A48D-3B57-47B7-835F-B30B1608D5BDQ39240834-B48ED680-95C4-4AB4-85C1-D11B7DC43E93Q39358170-90A5BD05-E156-4E89-BC6E-936D4FD27003Q39373990-51289D26-E2B7-4D47-964B-C517E781AEB4Q39586070-9D80EE9C-EE36-4E72-B94A-3A6441443101Q39652604-A927A03D-66D8-49AF-9872-51B813147868Q41248731-9A2D483D-6C6B-4E9C-996C-7A9D04EBCB75Q41652067-6238A495-3165-4593-907F-85370FB5D455Q41814226-1C7FD249-FB6A-4ACA-9CFF-468F12327ED3Q45061832-0876C920-30EF-4FEE-8AAE-4B4DB0B0638BQ45358303-518055BD-87E5-4232-82C8-83C2A871BEBD
P2860
In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
In mice with type 2 diabetes, ...... nesis after hindlimb ischemia.
@ast
In mice with type 2 diabetes, ...... nesis after hindlimb ischemia.
@en
In mice with type 2 diabetes, ...... nesis after hindlimb ischemia.
@nl
type
label
In mice with type 2 diabetes, ...... nesis after hindlimb ischemia.
@ast
In mice with type 2 diabetes, ...... nesis after hindlimb ischemia.
@en
In mice with type 2 diabetes, ...... nesis after hindlimb ischemia.
@nl
prefLabel
In mice with type 2 diabetes, ...... nesis after hindlimb ischemia.
@ast
In mice with type 2 diabetes, ...... nesis after hindlimb ischemia.
@en
In mice with type 2 diabetes, ...... nesis after hindlimb ischemia.
@nl
P2093
P356
P1433
P1476
In mice with type 2 diabetes, ...... nesis after hindlimb ischemia.
@en
P2093
Anne M Pippen
Brian H Annex
Donghua Xie
Surovi Hazarika
Yongjun Li
P304
P356
10.2337/DB06-0999
P407
P577
2007-03-01T00:00:00Z